Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Magle Biopolymers A/S
A/S
Active
Advertising protection
CVR 14893695
Københavnsvej 140, 4600
Køge
Manufacture of starches and starch products
·
NACE 1062
Est. 1991 · 35 years old
56 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of starches and starch products
/
Magle Biopolymers A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
97M
73M
49M
24M
0M
2021: 77M
77M
2021
2022: 78M (+1% vs 2021)
78M
+1%
2022
2023: 75M (-4% vs 2022)
75M
-4%
2023
2024: 42M (-44% vs 2023)
42M
-44%
2024
2025: 24M (-43% vs 2024)
24M
-43%
2025
EBITDA
DKK millions
56M
33M
10M
-12M
-35M
2021: 38M
38M
2021
2022: 31M (-18% vs 2021)
31M
-18%
2022
2023: 30M (-3% vs 2022)
30M
-3%
2023
2024: -3M (-110% vs 2023)
-3M
-110%
2024
2025: -17M (-467% vs 2024)
-17M
-467%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
23.935
41.973
75.396
78.343
76.951
Staff expenses
-39.158
-44.768
-45.849
-46.929
-39.203
EBITDA
-16.509
-2.795
29.548
31.413
37.749
Depreciation & amort.
-53.523
-19.223
-18.564
-16.691
-14.806
EBIT
-70.032
-22.018
10.983
14.723
22.943
Net financials
-11.875
-5.236
-6.374
-4.337
-1.701
Profit before tax
-81.907
-27.254
4.609
10.386
21.242
Tax
-16.208
-5.995
983
2.211
4.630
Net profit
-65.700
-21.259
3.627
8.174
16.612
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
286.923
330.628
359.924
344.581
284.901
Equity
83.170
155.442
187.906
184.279
134.765
Long-term debt
0
11.082
54.731
63.661
45.845
Short-term debt
203.753
146.043
90.071
70.797
83.857
Total debt
203.753
157.125
144.803
134.458
129.702
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-69,0 %
This company
2021
2025
Equity ratio
29,0 %
This company
38,2 %
Market median
This company
Market median
24% below market
2021
2025
Return on equity
-79,0 %
This company
18,4 %
Market median
This company
Market median
529% below market
2021
2025
Net profit margin (of gross profit)
-274,5 %
This company
2021
2025
Asset turnover (of gross profit)
0,08×
This company
2021
2025
Debt / equity
2,45×
This company
0,62×
Market median
This company
Market median
295% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Magle Biopolymers A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
